These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37597591)

  • 21. Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction.
    Hamada T; Kubo T; Kawai K; Nakaoka Y; Yabe T; Furuno T; Yamada E; Kitaoka H;
    ESC Heart Fail; 2023 Feb; 10(1):223-233. PubMed ID: 36193578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK.
    Cea-Soriano L; Fowkes FGR; Johansson S; Allum AM; García Rodriguez LA
    BMJ Open; 2018 Jan; 8(1):e018184. PubMed ID: 29358428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008.
    Schneider PM; Pellegrini CN; Wang Y; Fein AS; Reynolds MR; Curtis JP; Masoudi FA; Varosy PD
    Am J Cardiol; 2014 Jun; 113(12):2052-6. PubMed ID: 24793671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin Therapy Reduces Future Risk of Lower-Limb Amputation in Patients With Diabetes and Peripheral Artery Disease.
    Hsu CY; Chen YT; Su YW; Chang CC; Huang PH; Lin SJ
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2373-2381. PubMed ID: 28398564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF.
    Camm AJ; Steffel J; Virdone S; Bassand JP; Fox KAA; Goldhaber SZ; Goto S; Haas S; Turpie AGG; Verheugt FWA; Misselwitz F; Herreros RC; Kayani G; Pieper KS; Kakkar AK;
    Eur Heart J Open; 2023 May; 3(3):oead051. PubMed ID: 37293139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of lower extremity peripheral artery disease in veterans.
    Willey J; Mentias A; Vaughan-Sarrazin M; McCoy K; Rosenthal G; Girotra S
    J Vasc Surg; 2018 Aug; 68(2):527-535.e5. PubMed ID: 29588132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction.
    McCullough PA; Mehta HS; Barker CM; Van Houten J; Mollenkopf S; Gunnarsson C; Ryan M; Cork DP
    Clin Cardiol; 2021 Sep; 44(9):1192-1198. PubMed ID: 34342033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in Use of Cardioprotective Medication in Peripheral Artery Disease: A Nationwide Study.
    Kamil S; Sehested TSG; Houlind K; Lassen JF; Gislason GH; Dominguez H
    J Am Heart Assoc; 2021 Aug; 10(15):e020333. PubMed ID: 34315233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.
    Kocabaş U; Ergin I; Kıvrak T; Yılmaz Öztekin GM; Tanık VO; Özdemir İ; Avcı Demir F; Doğduş M; Şen T; Altınsoy M; Üstündağ S; Urgun ÖD; Sinan ÜY; Uygur B; Yeni M; Özçalık E
    ESC Heart Fail; 2023 Dec; 10(6):3677-3689. PubMed ID: 37804042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse cardiovascular outcomes in relation to suboptimal antithrombotic therapy use in patients undergoing peripheral artery disease angioplasty: lost opportunities?
    Bodansky DM; Allon IR; Apostolakis S; Lip GY
    Int J Clin Pract; 2015 Feb; 69(2):162-8. PubMed ID: 24898695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF.
    Bozkurt B; Savarese G; Adamsson Eryd S; Bodegård J; Cleland JGF; Khordoc C; Kishi T; Thuresson M; Vardeny O; Zhang R; Lund LH
    JACC Heart Fail; 2023 Oct; 11(10):1320-1332. PubMed ID: 37354145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004.
    Pande RL; Perlstein TS; Beckman JA; Creager MA
    Circulation; 2011 Jul; 124(1):17-23. PubMed ID: 21690489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Statin Therapy With Major Adverse Cardiovascular and Limb Outcomes in Patients With End-stage Kidney Disease and Peripheral Artery Disease Receiving Maintenance Dialysis.
    Lo HY; Lin YS; Lin DS; Lee JK; Chen WJ
    JAMA Netw Open; 2022 Sep; 5(9):e2229706. PubMed ID: 36048442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating Guideline Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction Post-coronary Artery Bypass Grafting.
    Kabulski GM; Boughner T; Szymanski TW; Sokos GG; Kido K
    J Pharm Pract; 2023 Dec; 36(6):1370-1374. PubMed ID: 35926866
    [No Abstract]   [Full Text] [Related]  

  • 36. Resource use and costs in high-risk symptomatic peripheral artery disease patients with diabetes and prior acute coronary syndrome: a retrospective analysis.
    Reed Chase M; Friedman HS; Navaratnam P; Heithoff K; Simpson RJ
    Postgrad Med; 2016; 128(2):170-9. PubMed ID: 26788980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery system.
    Reynolds K; Mues KE; Harrison TN; Qian L; Chen S; Hsu JY; Philip KJ; Monda KL; Reading SR; Brar SS
    Vasc Med; 2020 Feb; 25(1):3-12. PubMed ID: 31512991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy treatment patterns at hospital discharge and clinical outcomes among patients with heart failure with reduced ejection fraction.
    Wongsalap Y; Poolpun D; Keawhai K; Kitpluem N; Pansiri P; Malaimat S; Senthong V; Kengkla K
    Chronic Dis Transl Med; 2023 Jun; 9(2):154-163. PubMed ID: 37305111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial.
    Mathew RO; Maron DJ; Anthopolos R; Fleg JL; O'Brien SM; Rockhold FW; Briguori C; Roik MF; Mazurek T; Demkow M; Malecki R; Ye Z; Kaul U; Miglinas M; Stone GW; Wald R; Charytan DM; Sidhu MS; Hochman JS; Bangalore S
    Circ Cardiovasc Qual Outcomes; 2022 Oct; 15(10):e008995. PubMed ID: 36193750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.